Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kamishoyosan for premenstrual syndrome
jRCTs061220001Completed
- Sponsor
- Tsumura & Co.
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of gamisoyosan in premenstrual syndrome (PMS) (2 arms), sponsored by Tsumura & Co. Started Apr 2022; status: completed.
02
Drugs
gamisoyosan
03
Conditions
premenstrual syndrome (PMS)
Beyond the preview
Go deeper on jRCTs061220001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061220001.